scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1009739712 |
P356 | DOI | 10.1186/1471-2261-12-93 |
P932 | PMC publication ID | 3502533 |
P698 | PubMed publication ID | 23092442 |
P5875 | ResearchGate publication ID | 232647375 |
P50 | author | Richard A. Hansen | Q37371133 |
Susan J Blalock | Q46738766 | ||
P2093 | author name string | Wanzhu Tu | |
Michael D Murray | |||
Hisham Aljadhey | |||
D Craig Brater | |||
P2860 | cites work | Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 |
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies | Q28036762 | ||
Analgesic use and risk of subsequent hypertension in apparently healthy men | Q28191794 | ||
Nonnarcotic analgesic use and the risk of hypertension in US women | Q28194095 | ||
Hemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals | Q28372086 | ||
Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension | Q28388642 | ||
What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes | Q29615705 | ||
Using prescription claims data for drugs available over-the-counter (OTC). | Q31119847 | ||
Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril | Q31566106 | ||
The global burden of chronic diseases: overcoming impediments to prevention and control | Q34323994 | ||
Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization? | Q34368055 | ||
The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons | Q34376740 | ||
Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study | Q34404248 | ||
Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients | Q34514691 | ||
Standards of medical care in diabetes--2007. | Q34595288 | ||
Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis | Q34726199 | ||
Structure, functions, and activities of a research support informatics section | Q35095969 | ||
Acetaminophen increases blood pressure in patients with coronary artery disease | Q38498688 | ||
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs | Q52956338 | ||
Too much ado about propensity score models? Comparing methods of propensity score matching. | Q53012603 | ||
Effect of ibuprofen on blood pressure control by propranolol and bendrofluazide | Q70200815 | ||
The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil | Q72231522 | ||
Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine | Q72250790 | ||
Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide | Q72572952 | ||
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines | Q73027994 | ||
New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study | Q80293321 | ||
Beta blockers and renal function: a reappraisal. | Q39450657 | ||
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group | Q39605645 | ||
Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics | Q39753993 | ||
Effects of Indomethacin Alone and during Diuretic or β-Adrenoreceptor-Blockade Therapy on Blood Pressure and the Renin System in Essential Hypertension | Q40570494 | ||
NSAIDs, antihypertensive agents and loss of blood pressure control. | Q40611050 | ||
Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients | Q42557596 | ||
Comparison of changes in blood pressure measurements and antihypertensive therapy in older, hypertensive, ambulatory care patients prescribed celecoxib or rofecoxib | Q42613243 | ||
Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors | Q43967728 | ||
Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study | Q43994295 | ||
Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis | Q44193431 | ||
Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors | Q44297774 | ||
Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics | Q44743351 | ||
Relationship between COX-2 specific inhibitors and hypertension | Q44958643 | ||
The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide | Q45048202 | ||
The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus | Q45236720 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | arterial hypertension | Q41861 |
P304 | page(s) | 93 | |
P577 | publication date | 2012-10-24 | |
P1433 | published in | BMC Cardiovascular Disorders | Q15753126 |
P1476 | title | Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension | |
P478 | volume | 12 |